Tagged with Emerging Markets

Bettina Bauer – Vice President, Global Commercial Product Strategy, HIV, COVID-19 & Emerging Viruses, Gilead Sciences
How Can the Generics Industry Up its Game on Essential Medicine Access?
Are Emerging Markets Back on Pharma’s Priority List?
What’s on the Mind of GSK Country Managers?
Patrick van der Loo – Regional President Middle East, Russia and Africa (MERA), Pfizer
Luis Arosemena – SVP Emerging Markets, GSK
Mahender Nayak – Head, India, CIS, Middle East, Turkey & Africa, Takeda
Further Predictions for 2019 – Tech, Value-Based Pricing & Emerging Markets
Africa: The Launchpad for Indian Pharma
Interview: Cesar M. Rengifo – Senior Vice President & Area Director Emerging Markets West, GSK, Brazil
Interview: Kalle Känd – CEO, Acino, Switzerland
Richard Saynor – SVP, Classic & Established Products, GSK, Singapore
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here